Vancouver, British Columbia, May 8th, 2025 – TheNewswire - CAVA Healthcare Inc, (the “Company”) is pleased to announce the appointment of Barbara Sharp as its new Chief Executive Officer (CEO), effective immediately.  She has also been appointed to serve as a Director of the Company until next Annual General Meeting.

Barbara brings a wealth of leadership experience across public, private, and nonprofit sectors, with a career spanning over three decades in executive management, labour relations, conflict resolution, and public governance. She has held prominent roles including Mayor of the City of North Vancouver, Divisional Director of Employee Relations for The Salvation Army (BC Division), and Faculty member at both BCIT and Kwantlen Polytechnic University.

Most recently, Barbara served as Special Advisor for Conflict Resolution at the University of the Fraser Valley, and as a member of the Employment Assistance and Appeal Tribunal. She is also the founder of Barbara Sharp Solutions, a consulting firm providing strategic planning, HR training, and organizational development services.

Her academic credentials include a Master of Arts in Conflict Analysis and Management from Royal Roads University, ongoing coursework in Trauma-Informed Practices at Wilfrid Laurier University, and multiple professional certifications in labour relations, mediation, and education.  “I’m honoured to lead CAVA Healthcare and excited to work with this incredible team. Together, we’ll focus on innovation, collaboration, and making a positive impact on healthcare in our communities.”

“We are thrilled to welcome Barbara Sharp to lead CAVA Healthcare at this pivotal moment of growth and transformation,” said Prof. Wilfred Jefferies, Board Chair. “Barbara’s experience in building collaborative partnerships, leading complex organizations, and her deep commitment to community values align perfectly with our mission.”  Barbara will lead CAVA's strategic direction with a focus on innovation, equity, and sustainable development in the healthcare sector.

For media enquiries or further information, please contact Adrian Wade at cavahealthcare@gmail.com.

On Behalf of the Board of Directors

Adrian Wade, Ph.D.
COO and Director
Investor Relations and Corporate Communications

Website: cavahealthcare.ca

CAVA IS FOCUSED ON ENHANCING OPTIMAL HEALTH BY PREDICTING, PREVENTING AND ALLEVIATING DISEASE

Cava is a specialty biotechnology company focused on advancing drug development to address unmet medical needs in neurodegeneration, inflammation, and restoration of immune function.  The Company has a patent protected portfolio of intellectual property and technology, concentrated on the development of a treatment for Alzheimer’s Disease and various oncology related biomarkers and treatments.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995.  All statements in this press release that are not purely historical are forward-looking statements and include statements regarding beliefs, plans, expectations, and orientations regarding the future including, without limitation, matters related to the Company’s current and planned research and development programs, including in respect of the prosecution and maintenance of the patent portfolio, and the Company's prospect of success in executing its proposed plans.  Often, but not always, forward-looking statements can be identified by words such as “will”, “plans”, “expects”, “may”, “intends”, “anticipates”, “believes”, “proposes” or variations of such words including negative variations thereof and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved.  Forward-looking statements are based on certain assumptions regarding the Company, including, without limitation, expected growth, results of operations and research and development activities (including in respect of the patent portfolio), results of operations, performance, industry trends, growth opportunities, and that the Company will be able to obtain the financing required to carry out its planned future business activities, retain and attract qualified research personnel and obtain and/or maintain the necessary intellectual property rights it needs to carry out its future business activities.

Actual results could differ from those projected in any forward-looking statements due to numerous factors including, risks and uncertainties relating to the actual results of research and development programs, the inability of the Company, to, among other things, protect its intellectual property, obtain any required governmental, regulatory or stock exchange approvals, permits, consents or authorizations required, commercialize any therapeutic and diagnostic technologies, execute its proposed business plans, pursue business partnerships, complete its research and development programs as planned, and obtain the financing required to carry out its planned future activities.  Other factors such as general economic, market or business conditions or changes in laws, regulations and policies affecting the Company's industries may also adversely affect the future results or performance of the Company.  These forward-looking statements are made as of the date of this press release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements.  Although the Company believes that the statements, beliefs, plans, expectations, intentions, and assumptions contained in this press release are reasonable, there can be no assurance that those statements, beliefs, plans, expectations intentions or assumptions will prove to be accurate.  Readers should consider all of the information set forth herein and should also refer to other periodic reports provided by the Company from time-to-time.  These reports and the Company’s filings are available at www.sedar.com.

Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements.

Copyright (c) 2025 TheNewswire - All rights reserved.